ASP ISOTOPES INC. - Form 144 – Report of proposed sale of securities
Form 144 – Report of proposed sale of securities
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
FORM 144 – REPORT OF PROPOSED SALE OF SECURITIES
ASPI stockholders are advised that on 13 April 2026, a Form 144 has been filed with the U.S. Securities
and Exchange Commission.
A copy of the Form 144 can be found at:
sec.gov/Archives/edgar/data/1921865/000147793226002187/xsl144X01/primary_doc.xml
The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.
14 April 2026
Sponsor
Valeo Capital Proprietary Limited
Date: 14-04-2026 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
